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A n 86-year-old woman with end-stage renal disease(etiology unknown) presented with left flank pain for
ten hours. She was hypotensive and had a firm, exquisitely
tender left flank mass. Computed tomography (CT) scan of the
abdomen revealed a 20 cm left renal mass with extensive fatty
tissue and associated retroperitoneal hemorrhage (Fig. 1). The
patient died from hemorrhagic shock. Based on the large peri-
renal fatty masses and the presence of a vessel extending into the
renal parenchyma (Fig. 2), we concluded this was a kidney
angiomyolipoma.1
Kidney angiomyolipomas are benign renal neoplasms,
usually detected incidentally on imaging. Approximately
80 % occur spontaneously as in this case, while 20 % occur
in association with tuberous sclerosis complex.2 As the lesions
increase in size, the vascular supply becomes aneurysmal and
hemorrhage risk increases. In one study, the risk of hemor-
rhage in lesions larger than eight cm was 25–50 %.3
Management is based on the size of the lesion and the
presence of symptoms, with a shift toward less invasive
treatments. Arterial embolization is used to reduce the size of
angiomyolipomas,4 and regrowth does not occur after
successful embolization. Some authors suggest arterial embo-
lization if the tumor is symptomatic or greater than four cm.5
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Figure 1. CT scan of the abdomen showing retroperitoneal
hemorrhage (short arrows) and areas of fatty tissue (arrow heads).
Figure 2. CT scan of the abdomen showing the vessel extending to
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